|
|
||||||||||||
|
|
||||||||||||||||||
Cornerstone Biopharma Press Release - Cornerstonebiopharma.com |
|
20 MAR |
Cornerstone BioPharma, Inc. Names George Esgro Vice President Of Sales And Marketing |
| Specialty pharmaceutical company builds executive team to drive strategic sales and marketing initiatives |
|
20 MAR |
Cornerstone BioPharma, Inc. Names George Esgro Vice President Of Sales And Marketing |
| Specialty pharmaceutical company builds executive team to drive strategic sales and marketing initiatives |
|
06 MAR |
Cornerstone Biopharma, Inc. Introduces New Allerx® Dose Pack |
| Specialty pharmaceutical company releases new product for Allergic Rhinitis |
|
20 JAN |
Cornerstone Biopharma, J-med Pharmaceuticals And Sovereign Pharmaceuticals Settle Pending Litigation Concerning U.s. Patent No. 6,270,796 And Allerx™ Dose Pack |
| Cornerstone BioPharma (“Cornerstone”) of Cary, North Carolina, and J-Med Pharmaceuticals (“J-Med”) of Boston, Massachusetts, today announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd., (“Sovereign”) of Fort Worth, Texas, in connection with U.S. Patent No. 6,270,796 (“the ‘796 patent”). |
|
09 NOV |
Cornerstone Biopharma, Inc. Obtains Exclusive Licensing Rights For Spectracef |
| Triangle-based specialty pharmaceutical company to serve $1.3 billion per year oral cephalosporin market |
| | Sitemap| Press Release Sitemap| Latest Companies| Buddies| Articles | PR Guidelines | Privacy Policy| Terms of Use| Contact Us |
|